Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Pharmaceutical executives share their outlook on the industry's future regarding drug costs, patent expirations, and upcoming agreements.

20 Jan, 2026

Three companies get positive endorsement from the SEC for their semaglutide formulations.

19 Jan, 2026

Pharmaceutical companies increase prices in 2026. What will be your additional expenses? - USA Today

18 Jan, 2026

Competition Intensifies in Weight-Loss Medication Market as Generics Approach Novo and Lilly

18 Jan, 2026